| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 09/20/2006 | CN1835749A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors |
| 09/20/2006 | CN1275966C Pyrido-pyrido-pyrrolo pyrrolo-indole and pyrido-pyrrolo pyrrolo carbazole derivatives, method for prodn. thereof and pharmaceutical compsns. contg. said derivatives |
| 09/19/2006 | US7109377 Synthesis of combinatorial libraries of compounds reminiscent of natural products |
| 09/19/2006 | US7109340 Substituted tetrahydro-1H-pyrazolo [3,4-c] pyridines, compositions comprising them, and use |
| 09/19/2006 | US7109338 For use in the prophylaxis and the treatment of Picornavirus and human rotavirus infections. |
| 09/19/2006 | US7109235 Microtubule stabilizing compounds |
| 09/19/2006 | US7109228 Pyrazole derivatives |
| 09/19/2006 | CA2232195C Isoxazolidine derivatives |
| 09/14/2006 | WO2006096325A1 Oxepane isomer of 42-o-(2-hydroxy)ethyl-rapamycin |
| 09/14/2006 | WO2006095185A1 39-desmethoxy derivatives of rapamycin |
| 09/14/2006 | WO2006094934A1 Substituted oxa-diaza-spiro-[5.5]-undecanone derivatives and their use as neurokinin antagonists |
| 09/14/2006 | WO2006094682A1 Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds |
| 09/14/2006 | WO2006094662A1 New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal |
| 09/14/2006 | US20060205769 Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity |
| 09/14/2006 | US20060205766 Process for making crystalline form I of clopidogrel hydrogen sulphate |
| 09/14/2006 | US20060205765 1-{1-[4-(3-amino-5-phenyl-1H-pyrazolo[3,4-b]pyridin-6-yl)benzyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one; anticarcinogenic agents |
| 09/14/2006 | US20060205757 39-desmethoxyrapamycin, compositions and methods of use thereof |
| 09/14/2006 | US20060205756 Antitussives |
| 09/14/2006 | US20060205744 Fused heterocyclic derivatives as ppar modulators |
| 09/14/2006 | US20060205742 Heterocyclic compounds and cerebral function improvers containing the same as the active ingredient |
| 09/14/2006 | US20060205718 Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives |
| 09/14/2006 | US20060205710 Spiroazacyclic compounds as monoamine receptor modulators |
| 09/14/2006 | US20060205707 adenosine triphosphate inhibitors used for the treatment of cancer; anticarcinogenic agents |
| 09/14/2006 | US20060205676 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one |
| 09/14/2006 | CA2602010A1 Oxepane isomer of 42-o-(2-hydroxy)ethyl-rapamycin |
| 09/14/2006 | CA2600640A1 39-desmethoxy derivatives of rapamycin |
| 09/14/2006 | CA2599250A1 Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds |
| 09/14/2006 | CA2598530A1 Substituted oxa-diaza-spiro-[5.5]-undecanone derivatives and their use as neurokinin antagonists |
| 09/13/2006 | CN1832938A N-heterocyclyl phenyl-substituted cyclic ketoenols |
| 09/12/2006 | US7105675 Analgesics with use of treating pain and as immunomodulators and for treatment of drug dependence |
| 09/12/2006 | US7105667 Fused heterocyclic compounds and use thereof |
| 09/12/2006 | US7105663 Derivatives of pyrimido[6,1-a]isoquinolin-4-one |
| 09/12/2006 | US7105535 Such as n-{4-[4-(1,3-benzoxazol-2-yl)pyrazol-3-yl]phenyl}-n'-methyl urea; synthesis; cancer, cell proliferative disorders, viral infections, autoimmune diseases, neurodegenerative disorders |
| 09/12/2006 | US7105529 A novel compound for treating alopecia induced by cancer chemotherapy or radiotherapy |
| 09/12/2006 | US7105492 Antitumor agents |
| 09/08/2006 | WO2006094236A1 N-phenyl benzamide derivatives as sirtuin modulators |
| 09/08/2006 | WO2006093745A1 Purification of rapamycin |
| 09/08/2006 | WO2006093743A1 Recovery of cci-779 from mother liquors |
| 09/08/2006 | WO2006093514A2 Aryl and arylalkylenyl substituted thiazoloquinolines and thiazolonaphthyridines |
| 09/08/2006 | WO2006008091A3 Oxidative degradation products of atorvastatin calcium |
| 09/08/2006 | CA2599989A1 N-phenyl benzamide derivatives as sirtuin modulators |
| 09/08/2006 | CA2599582A1 Purification of rapamycin |
| 09/08/2006 | CA2599580A1 Recovery of cci-779 from mother liquors |
| 09/07/2006 | US20060199956 Bicyclic heterocycles as HIV integrase inhibitors |
| 09/07/2006 | US20060199836 Novel thienopyridine compounds, and methods of use thereof |
| 09/07/2006 | US20060199833 Novel chemiluminescent compounds and their use |
| 09/07/2006 | US20060199815 NK1 antagonists |
| 09/07/2006 | US20060199814 Chemical Intermediate |
| 09/07/2006 | US20060199812 Method of conjugating aminothiol containing molecules to vehicles |
| 09/07/2006 | US20060199794 avoid the adverse side effects associated with non-selective receptor interactions; 1-(4-Fluorobenzyl)-2-(4-methoxybenzyl)-8-methyl-1,2,8-triaza-spiro[4.5]decan-3-one; 1-oxa-4,9-diaza-spiro[5.5]undecan-3-one compounds as monoamine receptor modulators; schizophrenia, psychosis, migraine, hypertension |
| 09/07/2006 | US20060198870 Medical devices containing rapamycin analogs |
| 09/06/2006 | EP1698630A1 New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations |
| 09/06/2006 | EP1698627A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/06/2006 | EP1697384A1 Pyrido- and pyrimidopyrimidine derivatives as anti-proliferative agents |
| 09/06/2006 | EP1697383A1 Process for the purification of macrolides |
| 09/06/2006 | EP1697382A2 Rifamycin analogs and uses thereof |
| 09/06/2006 | EP1697377A1 Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 09/06/2006 | EP1697359A1 Muscarinic agonists as therapeutic compounds |
| 09/06/2006 | EP1697355A2 Amidino compounds as cysteine protease inhibitors |
| 09/06/2006 | EP1696930A1 Tricyclic 1-((3-indol-3-yl)carbonyl)piperazine derivatives as cannabinoid cb1 receptor agonists |
| 09/06/2006 | EP1696914A1 3-cyano-quinoline derivatives with antiproliferative activity |
| 09/06/2006 | CN1829722A Regioselective synthesis of CCI-779 |
| 09/06/2006 | CN1829721A Spiro '1-azabicyclo' 2.2.2! octan-3,5'-oxazolidin - 2'-one! derivatives with affinity to the alpha7 nicotinic acetylcholine receptor |
| 09/06/2006 | CN1829718A Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 09/06/2006 | CN1273472C Garland chrysanthemum analogue, its synthesis method and use |
| 09/05/2006 | US7101908 Nontoxic treatment for infections from cytomegalovirus |
| 09/05/2006 | US7101891 Compounds and pharmaceutical compositions for inhibiting MRP1 |
| 09/05/2006 | US7101428 stability of gamma-quinacridone pigment during milling by addition of 2,9-dichloroquinacridone |
| 08/31/2006 | WO2006060614A9 Methods for preparing pimecrolimus |
| 08/31/2006 | US20060194823 Sulfonamido-macrocycles as Tie2 inhibitors and the salts thereof, a pharmaceutical composition comprising these compounds, the method of preparing and the use thereof |
| 08/31/2006 | US20060194819 Activation specific inhibitors of nf-kb and method of treating inflammatory processes in cardio-vascular diseases |
| 08/31/2006 | US20060194794 oxadiazoles such as 2-({[5-(3,4,5,6-Tetrahydro-2H-[1,2']bipyridinyl-4-yl)-[1,3,4]oxadiazol-2-ylmethyl]-amino}-methyl)-phenylamine exhibiting vasopressin antagonistic activity and can be used in the treatment of dysmenorrhea |
| 08/31/2006 | US20060194294 Process for the recovery of staurosporine from a fermentation broth |
| 08/30/2006 | CN1826333A Diamine derivatives |
| 08/29/2006 | US7098330 Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors |
| 08/29/2006 | US7098234 Indole derivatives, process for preparation of the same and use thereof |
| 08/29/2006 | CA2396738C Thiazole derivatives as active superoxide radical inhibitors |
| 08/24/2006 | WO2006089100A1 Benzoxazole carboxamides for treating cinv and ibs-d |
| 08/24/2006 | WO2006078891A3 Imidazolylmethyl and pyrazolylmethyl heteroaryl derivatives |
| 08/24/2006 | WO2006020561A3 Antibacterial agents |
| 08/24/2006 | US20060189666 Alzheimer's disease; bridged bicycloalkyl sulphonamide and sulphamide derivatives; [9-endo]2',3', 4',5'-Tetrahydro-5'-(2.2.2-trifluoroethyl)spiro[3-{(E)-2-[5-(4-fluorophenyl)-1-methyl-1H-pyrazol-3-yl]ethenyl}-4-methyl bicyclo[4.2.1]non-3-ene]-9,3'-[1,2,5]thiadiazol-1',1'-dioxide |
| 08/24/2006 | US20060189652 7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide; reacting nitrogen heterocyclic compound with carbonylation agent selected from phosgene, diphosgene, triphosgene, aryl chloroformates, aralkyl chloroformates, alkyl chloroformates, cyclization |
| 08/24/2006 | US20060189643 Novel heterocyclic compounds having anti-HBV activity |
| 08/24/2006 | US20060189639 Antagonists of the mGlu receptor and uses thereof |
| 08/24/2006 | US20060189604 Gramnegative and Grampositive bacterial infections; substituted Piperidine derivatives specially optionally substituted pyrido [3,2, -b][1,4] thiazin-yl; 6-({(3R,4S)-3-Fluoro-1-[(R)-2-hydroxy-2-(2-methoxy-quinolin-8-yl)-ethyl]-piperidin-4-ylamino }-methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one; nontoxic |
| 08/24/2006 | US20060189602 Antiviral agent especially to treat hepatitis C virus infections; 5-Hydroxy-4-(7-methoxy-1,1-dioxo-1,2-dihydro-1 lambda 6-benzo[1,2,4]thiadiazin-3-yl)-2-(3-methyl-butyl)-6-thiophen-2-yl-2H-py-ridazin-3-one; side effects reduction |
| 08/24/2006 | US20060189601 Antibacterial agents |
| 08/24/2006 | US20060189597 Lactam compounds and pharmaceutical use thereof |
| 08/24/2006 | DE102004046142B4 Neue selektiv wirksame Substanzen zur Behandlung von Krankheiten, die durch Mykobakterien hervorgerufen werden, Verfahren zu ihrer Herstellung und ihre Verwendung Selectively new active substances for the treatment of diseases which are caused by mycobacteria, processes for their preparation and their use |
| 08/24/2006 | CA2597962A1 Benzoxazole carboxamides for treating cinv and ibs-d |
| 08/23/2006 | EP1692142A1 Process for preparing amide acetals |
| 08/23/2006 | EP1692140A1 Compositions useful as inhibitors of protein kinases |
| 08/23/2006 | EP1539133B1 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity |
| 08/23/2006 | EP1368358B1 Isoxazoline derivatives as anti-depressants |
| 08/23/2006 | CN1823081A Rapamycin carbohydrate derivatives |
| 08/23/2006 | CN1823073A CCI-779 isomer C |
| 08/23/2006 | CN1823072A Inhibitors of P38 and methods of using the same |
| 08/23/2006 | CN1823069A Process for synthesizing beta-lactamase inhibitor intermediates |
| 08/22/2006 | US7094780 3-aminoquinazolin-2,4-dione antibacterial agents |
| 08/22/2006 | US7094516 Benzobisazole compound and optical recording medium containing the compound |